Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 236 participants.
Also called NCT06345209
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 236 participants
- Registry
-
NCT06345209
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06345209. Randomized; double masking; primary purpose treatment. Start 2024-05 (anticipated); primary completion 2024-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Sirolimus-coated Coronary Balloon Dilatation Catheter
- Intervention (Device)
- Drug-coated Coronary Balloon Dilatation Catheter
- Lead sponsor
- BrosMed Medical Co., Ltd
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
Record details
- Record id
cardio:ct-nct06345209- Content hash
6ad168efe7ea9a98556c6a061f3632895fe7b48115b16618ef5f184f494709fe